Insightful Analysis on Economics, Markets & Global Affairs
- EUR/USDLoading…————
- XAU/USDLoading…————
- USD/TRYLoading…————
- EUR/TRYLoading…————
- XAU/TRYLoading…————
- Brent OilLoading…————
- S&P 500Loading…————
- UST Yield 10yLoading…————
- BIST 100Loading…————
- VIXLoading…————
Editor's Pick
Trending
Sep 12, 2026
Truck rates are already 35% above last year. Uber Freight says the holiday quarter could push them higher, and the cost lands on consumers.
Sep 13, 2026
Banks fled trucking's three-year bust. One lender stayed, absorbed the losses, and now controls who gets a truck and who doesn't.
Latest
Banks fled trucking's three-year bust. One lender stayed, absorbed the losses, and now controls who gets a truck and who doesn't.
Banks fled trucking's three-year bust. One lender stayed, absorbed the losses, and now controls who gets a truck and who doesn't.
Hershey's dividend just started growing again after a nearly two-year freeze, and the story behind that pause reveals how badly cocoa prices and tariffs hit the company.
Hershey's dividend just started growing again after a nearly two-year freeze, and the story behind that pause reveals how badly cocoa prices and tariffs hit the company.
GameStop's CEO bought 1 million shares at roughly $20 each, a move that signals confidence but leaves real questions about where the company is headed.
GameStop's CEO bought 1 million shares at roughly $20 each, a move that signals confidence but leaves real questions about where the company is headed.
Third Point owns Hut 8 stock and Riot debt, not two matching equity bets. The difference matters more than the headline figure.
Third Point owns Hut 8 stock and Riot debt, not two matching equity bets. The difference matters more than the headline figure.
A trial showing Wegovy works in young children gives Novo Nordisk a new market, but the company is under real pressure after losing ground to Eli Lilly.
A trial showing Wegovy works in young children gives Novo Nordisk a new market, but the company is under real pressure after losing ground to Eli Lilly.
BioMarin and Ascendis settled a global patent fight over a rare bone-growth drug, with Ascendis paying royalties of up to 20% on every sale through 2030.
BioMarin and Ascendis settled a global patent fight over a rare bone-growth drug, with Ascendis paying royalties of up to 20% on every sale through 2030.
Wall Street is calling it a "treat-cession": Americans are quietly pulling back on pet spending, and Chewy's numbers are starting to show it.
Wall Street is calling it a "treat-cession": Americans are quietly pulling back on pet spending, and Chewy's numbers are starting to show it.
Walgreens is shutting roughly 1,200 locations by 2027, and federal rules are quietly handing those customers to CVS.
Walgreens is shutting roughly 1,200 locations by 2027, and federal rules are quietly handing those customers to CVS.
